openPR Logo
Press release

Typhoid Vi Polysaccharide Vaccine Market 2023-32 : Industry Analysis, Size, Share, Growth And Forecast | Sanofi Pasteur SA, GlaxoSmithKline plc, Merck & Co. Inc., Pfizer Inc., Johnson & Johnson Private Limited

04-14-2023 12:02 PM CET | Health & Medicine

Press release from: The Business research company

Typhoid Vi Polysaccharide Vaccine Market

Typhoid Vi Polysaccharide Vaccine Market

The Business Research Company's global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032

Typhoid Vi Polysaccharide Vaccine Market Size, Growth Rate, And Forecast
The global typhoid Vi polysaccharide vaccine market size is expected to grow from $4.23 billion in 2022 to $4.96 billion in 2023 at a compound annual growth rate (CAGR) of 17.3%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The typhoid Vi polysaccharide vaccine market is expected to grow to $9.20 billion in 2027 at a CAGR of 16.7%.

Get A Free Sample Report Link
https://www.thebusinessresearchcompany.com/sample.aspx?id=8313&type=smp

Typhoid Vi Polysaccharide Vaccine Market Drivers
Rising typhoid prevalence is expected to propel the growth of the typhoid VI polysaccharide vaccine market going forward. Typhoid is an infection caused by the bacteria Salmonella typhi that can be fatal. It usually spreads through contaminated food or drink.

Learn More On The Typhoid Vi Polysaccharide Vaccine Market Report Here:
https://www.thebusinessresearchcompany.com/report/typhoid-vi-polysaccharide-vaccine-global-market-report

Typhoid Vi Polysaccharide Vaccine Market Segments
1) By Type: Child, Adult
2) By Route of Administration: Oral, Parenteral
3) By Application: Government Institutions, Private Sector, Other Applications

By Geography: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. Asia-Pacific was the largest region in the Typhoid Vi Polysaccharide Vaccine market.

Check Out Buying Options For The Typhoid Vi Polysaccharide Vaccine Market Report Here:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=8313

Typhoid Vi Polysaccharide Vaccine Market Key Players
Major players in the typhoid vi polysaccharide vaccine market are Sanofi Pasteur SA, GlaxoSmithKline plc, Merck & Co. Inc., Pfizer Inc., Johnson & Johnson Private Limited, AstraZeneca plc, Takeda Pharmaceutical Company Limited, Sun Pharmaceutical Industries Ltd., Mallinckrodt Pharmaceuticals, EMERGENT, PT Bio Farma, Bharat Biotech International Limited, Teva Pharmaceutical Industries Ltd., Novartis AG, and Mylan N.V.

The Business Research Company's "Global Typhoid Vi Polysaccharide Vaccine Market Report 2023" is a comprehensive report of the market, covering over 60 geographies and high level market segmentation per geography. The section on regional and country breakdowns examines the market in each geography as well as market size by region and country. Furthermore, it evaluates the market's historical and projected growth and identifies significant trends and strategies that businesses can use to expand their operations.

The Table Of Content For The Typhoid Vi Polysaccharide Vaccine Market Include:
1. Executive Summary
2. Typhoid Vi Polysaccharide Vaccine Market Characteristics
3. Typhoid Vi Polysaccharide Vaccine Market Trends And Strategies
4. Typhoid Vi Polysaccharide Vaccine Market - Macro Economic Scenario
5. Typhoid Vi Polysaccharide Vaccine Market Size And Growth
……
27. Typhoid Vi Polysaccharide Vaccine Market Competitive Landscape And Company Profiles
28. Key Mergers And Acquisitions In The Typhoid Vi Polysaccharide Vaccine Market
29. Typhoid Vi Polysaccharide Vaccine Market Future Outlook and Potential Analysis
30. Appendix

Contact us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Latest Trending Press Releases: https://www.thebusinessresearchcompany.com/press-release.aspx

Want To Know More About The Business Research Company?
The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialise in various industries including manufacturing, healthcare, financial services, chemicals, and technology.

Global Market Model - World's Most Comprehensive Database
The Business Research Company's flagship product, Global Market Model (www.thebusinessresearchcompany.com/global-market-model) is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets which help its users assess supply-demand gaps.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Typhoid Vi Polysaccharide Vaccine Market 2023-32 : Industry Analysis, Size, Share, Growth And Forecast | Sanofi Pasteur SA, GlaxoSmithKline plc, Merck & Co. Inc., Pfizer Inc., Johnson & Johnson Private Limited here

News-ID: 3013699 • Views:

More Releases from The Business research company

Segment Evaluation and Major Growth Areas in the Personalized Testing and Supplements Market
Segment Evaluation and Major Growth Areas in the Personalized Testing and Supple …
The personalized testing and supplements sector is gaining remarkable traction, driven by advancements in technology and a rising consumer focus on tailored health solutions. As more individuals seek customized wellness options, this market is set to experience substantial expansion in the coming years. Here's an in-depth look at its current valuation, key players, significant trends, and the main market segments shaping its future. Market Valuation and Expansion Forecast for Personalized Testing
Top Players and Market Competition in the Skin Microbiome Industry
Top Players and Market Competition in the Skin Microbiome Industry
The skin microbiome market is emerging as a significant area of interest due to growing awareness about the critical role of skin health and innovative skincare technologies. As research advances and consumer preferences shift towards more natural and science-backed products, this market is set to undergo substantial growth. Let's explore the current market size, key players, driving factors, and upcoming trends shaping the skin microbiome industry. Projected Expansion in the Skin
Key Strategic Developments and Emerging Changes Shaping the Upadacitinib Market Landscape
Key Strategic Developments and Emerging Changes Shaping the Upadacitinib Market …
The upadacitinib market is poised for significant expansion over the coming years, driven by advances in treatment options and increasing awareness of autoimmune diseases. This report delves into the market's current size, key drivers, major players, and the emerging trends shaping its future trajectory. Steady Growth Expected in Upadacitinib Market Size Through 2029 The market for upadacitinib is projected to reach $2.54 billion by 2029, growing at a robust compound annual
Analysis of Key Market Segments Driving the Alzheimer's Disease Diagnostic Market
Analysis of Key Market Segments Driving the Alzheimer's Disease Diagnostic Marke …
The Alzheimer's disease diagnostic sector is rapidly evolving as advancements in technology and healthcare infrastructure open new possibilities for early detection and personalized treatment. With rising awareness and innovative approaches, this market is poised for significant growth in the coming years. Let's explore the current market size, key drivers, leading companies, and emerging trends that are shaping this critical healthcare field. Projected Market Size and Growth Trends in Alzheimer's Disease Diagnostics

All 5 Releases


More Releases for Typhoid

What Is The Leading Driver Behind Escalating Typhoid Prevalence Fuels Expansion …
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. What Will the Typhoid Vi Polysaccharide Vaccine Industry Market Size Be by 2025? The typhoid vi polysaccharide vaccine sector has experienced swift expansion recently, projecting a rise from a valuation of $5.78 billion in 2024 to $6.71 billion the subsequent year, reflecting a substantial compound annual growth rate of
Leading Growth Driver in the Typhoid Antibody Testing Market in 2025: Increase I …
What Are the Market Size and Growth Forecast for the Typhoid Antibody Testing Market? In recent times, the typhoid antibody testing market has experienced substantial growth. The market is projected to increase from $7.83 billion in 2024 to $8.46 billion in 2025, indicating a compound annual growth rate (CAGR) of 8.2%. The historical growth rate can be linked to the growing collaboration efforts focused on creating new testing instruments, development
Testing Advancements: Typhoid Antibody Detection Market Growth 2024
The Business Research Company recently released a comprehensive report on the Global Typhoid Antibody Testing Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry. Ready to Dive into Something Exciting? Get Your Free Exclusive
Breakthrough Testing: Advancements in Typhoid Antibody Detection
The Business Research Company recently released a comprehensive report on the Global Typhoid Antibody Testing Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry. According to The Business Research Company's, the typhoid antibody testing
Typhoid Vi Polysaccharide Vaccine Market Size & Forecast 2033
The new report published by The Business Research Company, titled ""Typhoid Vi Polysaccharide Vaccine Global Market Report 2024 - Market Size, Trends, And Global Forecast 2024-2033"", delivers an in-depth analysis of the leading size and forecasts, investment opportunities, winning strategies, market drivers and trends, competitive landscape, and evolving market trends. As per the report, the typhoid vi polysaccharide vaccine market size has grown rapidly in recent years. It will grow from
Typhoid Vaccine Market is Thriving Worldwide with Top Companies like: Merck, Gla …
Los Angeles, United State, –The report titled Global Typhoid Vaccine Market is one of the most comprehensive and important additions to QY Research’s archive of market research studies. It offers detailed research and analysis of key aspects of the global Typhoid Vaccine market. The market analysts authoring this report have provided in-depth information on leading growth drivers, restraints, challenges, trends, and opportunities to offer a complete analysis of the global